Skip to content

Drug interactions

Certolizumab pegol + Human papillomavirus vaccine nonavalent

Severity: Minor

Certolizumab pegol and Human papillomavirus vaccine nonavalent: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

TNF inhibitors can blunt antibody responses to some vaccines, so the HPV vaccine may produce a weaker immune response in patients on certolizumab pegol. The vaccine is not live and is not unsafe, but protection may be reduced. The clinical significance for HPV is uncertain, and the vaccine is generally still recommended.

What this interaction means in plain words

Certolizumab pegol and Human papillomavirus vaccine nonavalent have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Evidence level: Low

Why it happens

Immunosuppression from TNF blockade may reduce vaccine-induced antibody responses.

What to do

Vaccinate when indicated, ideally before starting certolizumab pegol, and do not delay needed therapy. Complete the full vaccine series.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Certolizumab pegol and Human papillomavirus vaccine nonavalent, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Certolizumab pegol with Human papillomavirus vaccine nonavalent?

MediHelp rates the interaction as minor. Certolizumab pegol and Human papillomavirus vaccine nonavalent have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. TNF inhibitors can blunt antibody responses to some vaccines, so the HPV vaccine may produce a weaker immune response in patients on certolizumab pegol. The vaccine is not live and is not unsafe, but protection may be reduced. The clinical significance for HPV is uncertain, and the vaccine is generally still recommended.

How serious is the interaction between Certolizumab pegol and Human papillomavirus vaccine nonavalent?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Vaccinate when indicated, ideally before starting certolizumab pegol, and do not delay needed therapy. Complete the full vaccine series.

What other medicines interact with Certolizumab pegol?

MediHelp also lists interactions of Certolizumab pegol with, for example, Adenovirus types 4 and 7 live, Bcg intravesical live, Bcg vaccine live. The full list is on the Certolizumab pegol page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in